Milestone Pharmaceuticals (MIST) Operating Expenses (2018 - 2022)

Milestone Pharmaceuticals' Operating Expenses history runs 5 years deep, the most recent figure standing at $13.9 million for Q3 2022.

• Quarterly Operating Expenses rose 9.19% year-over-year to $13.9 million in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $13.9 million (down 66.98% YoY) and the FY2021 annual result came in at $51.1 million, up 14.06% from the prior year.
• Operating Expenses was $13.9 million for Q3 2022 at Milestone Pharmaceuticals, down from $14.6 million in the prior quarter.
• Across five years, Operating Expenses topped out at $16.4 million in Q4 2019 and bottomed at $3.3 million in Q2 2018.
• A 5-year average of $10.7 million and a median of $11.6 million in 2019 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2019 — Operating Expenses jumped 268.62% — and 2020, when it sank 54.71%.
• Milestone Pharmaceuticals' Operating Expenses stood at $8.5 million in 2018, then jumped by 92.93% to $16.4 million in 2019, then sank by 54.71% to $7.4 million in 2020, then surged by 97.62% to $14.7 million in 2021, then dropped by 5.73% to $13.9 million in 2022.
• Business Quant data shows MIST's Operating Expenses at $13.9 million in Q3 2022, $14.6 million in Q2 2022, and $14.7 million in Q4 2021.